Innovation

Medical Device Treats Sinusitis without Invasive Sinus Surgery

University of Minnesota
posted on 10/13/2011

This medical device treats chronic sinusitis by placing an implant in the affected sinus ostium with a minimally invasive approach instead of the usual invasive surgery used to open the nasal pathway. This relieves the inflammation and congestion of this sinus due to mucus buildup. The medical device features a unique delivery system to gain access to the ostium and a biodegradable implant with an open cross-section to both open the ostium and allow for normal cilia function.

Advantages

BENEFITS OF IMPLANTABLE MEDICAL DEVICE FOR TREATMENT OF SINUSITIS AND NASAL CONGESTION

  • Minimally-invasive approach leads to no cutting, less pain, and fast recovery
  • Proprietary, anatomically-designed tool for patient comfort and easy access under local anesthesia
  • No scoping required, as tactile feedback indicates successful sinus access
  • All-in-one design for single hand use and shorter procedures
  • Biodegradable implant mechanically facilitates sinus patency, decongestion, and relief from sinus inflammation

Innovation Details
 

Detailed Description

Medical Device for Chronic Sinusitis


Nasal Inflammation and Congestion Due to Sinus Infection


A medical device has been designed to relieve sinus congestion and pressure in chronic sinusitis patients. Sinusitis can be caused by infection, allergy symptoms, or autoimmune problems. In chronic cases lasting over 6-8 weeks, sinus surgery under general anesthesia is often required to relieve sinus congestion and inflammation of the nasal pathway. In healthy sinus activity, cilia in the ostium move mucus up a track into the nasal pathway where it can be drained. In cases of sinusitis this function is disabled, mucus builds up in the ostium, and the sinuses become infected. In order to correct chronic sinus infections, the ostium passageway must be opened and normal cilia function restored.


Relieves Sinus Congestion and Inflammation without Invasive Sinus Surgery


The medical device is designed to treat chronic sinus infections with a minimally invasive approach, with less pain to the patient, decreased recovery time, as well as greatly shortening the duration of the procedure. The medical device is composed of a nasal implant and a catheter delivery system. The delivery system uses a catheter to gain access to the ostium through the nostril. With a retrograde delivery motion, the medical device is able to deliver the implant through a later portal on the catheter into the congested ostium from the posterior of the opening. The implant includes an open cross-section to open the passageway while exposing the cilia to promote normal function. The implant is intended to open and maintain patency of the sinus ostia, facilitating mucus drainage and nasal healing. The implant is made from a biodegradable material such that extraction of the implant will not be required. The implant may be coated with pharmaceutical agents including antibiotics, anti-histamines, anti-inflamatory and mucus thinning drugs to further aid in healing. The medical device or implant may also be impregnated with radio-opaque material to make them visible via x-ray to verify proper placement.


BENEFITS OF IMPLANTABLE MEDICAL DEVICE FOR TREATMENT OF SINUSITIS AND NASAL CONGESTION

  • Minimally-invasive approach leads to no cutting, less pain, and fast recovery
  • Proprietary, anatomically-designed tool for patient comfort and easy access under local anesthesia
  • No scoping required, as tactile feedback indicates successful sinus access
  • All-in-one design for single hand use and shorter procedures
  • Biodegradable implant mechanically facilitates sinus patency, decongestion, and relief from sinus inflammation

File Number: UM Case Z09199-Z09200 

Other Information: Questions? Contact: Kevin Anderson, Technology Marketing Manager, Ph 612-624-8293 E-mail andersks@umn.edu


IP Protection

Patent Number(s): 2011/00156112

License Online

This innovation currently is not available for online licensing. Please contact Kevin Anderson at University of Minnesota for more information.

Request more info via email request more info
People

Case Manager:

Kevin Anderson Kevin Anderson

Innovations (4)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Profile
Related Tags

Find more innovations


February 11, 2009

8,815 members 16,688 innovations 159 organizations

Browse

Dr. Jörg Knäblein – Technology Scouting, Bayer Schering Pharma AG

"Through the iBridge Network, I was able to find a mouse model I was looking for. The collaboration available through the iBridge Network is crucial in driving innovation and I'll continue using it as a valued resource."  read more...